Stable nanovesicles for the delivery of microRNA in cancer
treatment

Researchers at ICMAB present a study on new
nanovesicles, known as quatsomes, which have been successfully
engineered to encapsulate and deliver microRNAs for the treatment
of tumors. These nanovesicles are produced by a simple GMP
compliant process, an unavoidable requirement for the clinical use
of new drug candidates. The study, published in Small, has been
highlighted in the Women in Materials Science issue of Advanced
Materials.